- Home
- CNC vs BAX Comparison
CNC vs BAX Comparison
Compare CNC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNC
- BAX
- Stock Information
- Founded
- CNC 1984
- BAX 1931
- Country
- CNC United States
- BAX United States
- Employees
- CNC N/A
- BAX N/A
- Industry
- CNC Medical Specialities
- BAX Medical/Dental Instruments
- Sector
- CNC Health Care
- BAX Health Care
- Exchange
- CNC Nasdaq
- BAX Nasdaq
- Market Cap
- CNC 14.3B
- BAX 12.4B
- IPO Year
- CNC 2001
- BAX N/A
- Fundamental
- Price
- CNC $38.42
- BAX $22.74
- Analyst Decision
- CNC Hold
- BAX Hold
- Analyst Count
- CNC 16
- BAX 9
- Target Price
- CNC $39.07
- BAX $30.78
- AVG Volume (30 Days)
- CNC 13.2M
- BAX 6.2M
- Earning Date
- CNC 10-29-2025
- BAX 11-07-2025
- Dividend Yield
- CNC N/A
- BAX 2.99%
- EPS Growth
- CNC N/A
- BAX N/A
- EPS
- CNC 4.07
- BAX N/A
- Revenue
- CNC $159,673,000,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- CNC $30.78
- BAX $7.39
- Revenue Next Year
- CNC N/A
- BAX $3.79
- P/E Ratio
- CNC $9.45
- BAX N/A
- Revenue Growth
- CNC 10.73
- BAX 3.60
- 52 Week Low
- CNC $25.08
- BAX $21.33
- 52 Week High
- CNC $73.50
- BAX $38.29
- Technical
- Relative Strength Index (RSI)
- CNC 72.73
- BAX 43.14
- Support Level
- CNC $34.41
- BAX $21.59
- Resistance Level
- CNC $39.28
- BAX $24.27
- Average True Range (ATR)
- CNC 1.13
- BAX 0.60
- MACD
- CNC 0.45
- BAX 0.11
- Stochastic Oscillator
- CNC 90.30
- BAX 41.50
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.